StockData
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (NAGE) stock

NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3011% below fair value
$2.04+0.03 (+1.49%)

Close on Nov 17, 2026Market cap $161.42MP/E 17.0Yield –

Earnings

Niagen Bioscience's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 3, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
$29.80M
-4.2% on a year earlier
Adjusted EPS, Q2 FY2026
$0.01
Latest guidance
Reaffirmed
Aug 4, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Niagen Bioscience's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 3, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close––––Filing
Q2 FY2026ended Jun 30, 2026Aug 4, 2026during market hours$29.80M-4.2%$0.01–Release
Q1 FY2026ended Mar 31, 2026May 6, 2026during market hours$31.50M+3.3%$0.07–Release
Q4 FY2025ended Dec 31, 2025Mar 4, 2026during market hours$33.80M+16.2%$0.05–Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025during market hours$34.00M+32.8%$0.05–Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025during market hours$31.10M+37.0%––Release
Q1 FY2025ended Mar 31, 2025May 7, 2025during market hours$30.50M+37.4%$0.06–Release
Q4 FY2024ended Dec 31, 2024Mar 4, 2025during market hours$29.10M+37.3%$0.09–Release
Q3 FY2024ended Sep 30, 2024Oct 31, 2024during market hours$25.60M+31.3%––Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024during market hours$22.70M+11.8%$0.00–Release
Q1 FY2024ended Mar 31, 2024May 8, 2024during market hours$22.20M-1.8%-$0.01–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Niagen Bioscience's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
e-commerce businessFY2026+10% – +15%+10% – +15%ReaffirmedAug 4, 2026
General & administrativeFY2026$3.00M – $4.00M$4.00M – $5.00MLoweredMay 6, 2026

Guidance vs results

The last range Niagen Bioscience gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue growth+25% – +30%+29.92%Σ4QWithin range

Guidance history

Every forecast Niagen Bioscience put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 4, 2026e-commerce businessFY2026+10% – +15%Reaffirmed
May 6, 2026General & administrativeFY2026$3.00M – $4.00MLowered
May 6, 2026Net salesFY2026+10% – +15%Reaffirmed
Mar 4, 2026General & administrativeFY2026$4.00M – $5.00MNew
Mar 4, 2026Net salesFY2026+10% – +15%New
Nov 4, 2025General and administrative expensesFY2025$8.00M – $9.00MNew
Nov 4, 2025net sales growthFY2025+25% – +30%New
Aug 6, 2025revenue growthFY2025+22% – +27%Raised
May 7, 2025Net sales growthFY2025+20% – +25%Raised
Mar 4, 2025General and administrative expensesFY2025$5.00M – $6.00MNew
Mar 4, 2025revenue growthFY2025+18%New
Oct 31, 2024revenue growthFY2024+15%Raised
Aug 7, 2024general and administrative expenseFY2024$1.50MLowered
Aug 7, 2024revenue growthFY2024+10% – +15%Lowered
May 8, 2024increase in general and administrative expenseFY2024$1.50M – $2.50MReaffirmed
May 8, 2024net sales growthFY2024+16%New
Mar 6, 2024increase in general and administrative expenseFY2024$1.50M – $2.50MNew
Nov 8, 2023revenue growthFY2023+14% – +16%Reaffirmed
Aug 9, 2023revenue growthFY2023+15%Raised
May 10, 2023reduction in general and administrative expenseFY2023$1.00M – $2.00MLowered

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Niagen Bioscience filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. News
  6. Results
  7. Results
  8. Update
  9. Update
  10. News
  11. Results
  12. Results
  13. Update
  14. Results
  15. Results

See a number that looks wrong?